Pharmaceuticals | Regulatory Rapporteur

Skip to main content
Skip to navigation

Pharmaceutical latest

NHS app opens access to trials for UK patients
2025-06-23T09:44:00+01:00
RegRapPod − InConversation with Hugues Malonne
2025-06-18T16:55:00+01:00
Sandbox of trust: Regulated AI for health promotion and disease prevention
2025-06-06T14:07:00+01:00
Navigating the FDA’s platform technology designation: Key insights and best practices for drug manufacturers
2025-05-02T13:42:00+01:00
Prescribing efficiency: Using generative artificial intelligence for pharmacovigilance
2025-05-02T13:42:00+01:00
Navigating orphan drug designation in the EU
2025-05-02T13:42:00+01:00

Recent advances and the near-term outlook for Advanced Therapy Medicinal Products in cancer treatment
2025-05-02T13:41:00+01:00
Advanced therapies: A maturing regulatory framework
2025-05-02T13:40:00+01:00
May 2025 – Contents
2025-05-01T14:56:00+01:00
Gene Therapy Medicinal Products: An examination of regulatory CMC requirements
2025-05-01T09:43:00+01:00
April 2025 – Contents
2025-04-03T14:48:00+01:00
Africa and the MENA region: Opportunities for growth
2025-04-03T14:08:00+01:00
March 2025 – Contents
2025-03-04T12:51:00+00:00
Data and AI: Readiness, research and real-world impact
2025-03-04T12:22:00+00:00
Pharmacies told to follow GPhC guidance on prescription-only weight-loss medicine
2025-02-13T17:37:00+00:00
Regulatory strategy implications for foetal medicine
2025-02-07T12:35:00+00:00
Immunological considerations in the development of novel vaccines
2025-02-07T12:35:00+00:00
February 2025 – Contents
2025-02-06T15:51:00+00:00

More pharmaceutical content